mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |